Journal of Clinical Investigation · 2004 · 109 citations · 34 references
Life SciencesCell BiologyImmunologyCell SignalingCellular ImmunologySignal TransductionCostimulatory SignalingCytokine BiologyImmune Cell SignalingT Cell ActivationT Cell BiologyT Cell Receptor SignalingCd4 Positive T CellsCellular ProliferationExtracellular Signal-regulated Kinase PathwayExtracellular Signal-regulated Kinase SignalingGlucocorticoid ResistanceMapk SignalingNf-κb SignalingT Cell Costimulatory Pathways
Glucocorticoids have potent immunosuppressive properties, but their effects are often modulated by the conditions prevailing in the local immune milieu. In this study we determined whether the action of glucocorticoids is influenced by the degree of signaling during T cell activation. We found that dexamethasone (Dex) effectively suppressed T cell receptor–induced (TCR-induced) proliferation of naive CD4+ T cells, through a mechanism involving downregulation of c-Fos expression and inhibition of activator protein-1 (AP-1), nuclear factor of activated T cells (NF-AT), and NF-κB transcriptional activity. However, enhancement of TCR signaling by CD28- or IL-2–mediated costimulation abrogated the suppressive effect of Dex on c-Fos expression and AP-1 function and restored cellular proliferation. The amount of signaling through the MAPK pathway was critical in determining the effect of Dex on T cell activation. In particular, costimulatory signaling via MAPK kinase (MEK) and extracellular signal–regulated kinase (ERK) was essential for the development of T cell resistance to Dex. Selective blockade of MEK/ERK signal transduction abolished the costimulation-induced resistance. In contrast, transmission of IL-2 signals via STAT5 and CD28 signals via NF-κB remained inhibited by Dex. These results imply that the immune system, by regulating the degree of local costimulation through MEK/ERK, can modify the effect of glucocorticoids on T cells. Moreover, these findings suggest that MAPK inhibitors may offer a therapeutic solution for glucocorticoid resistance.
34
Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor
Roland Schüle, Steven A. Kliewer, Lynn J. Ransone et al. · Cell · 1990 · 1.3K citations